SLC5A8 Antibody
-
中文名稱：SLC5A8兔多克隆抗體
-
貨號：CSB-PA021685GA01HU
-
規格：￥3,900
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：SLC5A8
-
別名：AIT antibody; Apical iodide transporter antibody; Electrogenic sodium monocarboxylate cotransporter antibody; MGC125354 antibody; SC5A8_HUMAN antibody; SLC5A8 antibody; SMCT antibody; SMCT1 antibody; sodium coupled monocarboxylate transporter 1 antibody; Sodium iodide related cotransporter antibody; Sodium iodide-related cotransporter antibody; Sodium-coupled monocarboxylate transporter 1 antibody; solute carrier family 5 iodide transporter member 8 antibody; Solute carrier family 5 member 8 antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Human SLC5A8
-
免疫原種屬：Homo sapiens (Human)
-
抗體亞型：IgG
-
純化方式：Antigen Affinity purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Acts as an electrogenic sodium (Na(+)) and chloride (Cl-)-dependent sodium-coupled solute transporter, including transport of monocarboxylates (short-chain fatty acids including L-lactate, D-lactate, pyruvate, acetate, propionate, valerate and butyrate), lactate, mocarboxylate drugs (nicotinate, benzoate, salicylate and 5-aminosalicylate) and ketone bodies (beta-D-hydroxybutyrate, acetoacetate and alpha-ketoisocaproate), with a Na(+):substrate stoichiometry of between 4:1 and 2:1. Catalyzes passive carrier mediated diffusion of iodide. Mediates iodide transport from the thyrocyte into the colloid lumen through the apical membrane. May be responsible for the absorption of D-lactate and monocarboxylate drugs from the intestinal tract. Acts as a tumor suppressor, suppressing colony formation in colon cancer, prostate cancer and glioma cell lines. May play a critical role in the entry of L-lactate and ketone bodies into neurons by a process driven by an electrochemical Na(+) gradient and hence contribute to the maintenance of the energy status and function of neurons.
-
基因功能參考文獻：
- The present work reveals much lower iodide affinity in the pocket of human SMCT1 analogous to the putative iodide-binding pocket of human NIS. PMID: 29131623
- Human SMCT1 is regulated by insulin and SGK1. PMID: 27488665
- Data suggest positive correlation between BMI (body mass index)/waist circumference in morbidly obese or obese subjects and jejunal mucosa mRNA abundance of SMCT1; BMI was not significantly correlated with mRNA abundance for glucose transporters SGLT1 and GLUT2 or the low-affinity short-chain fatty acid/monocarboxylate transporter SMCT2. PMID: 27801863
- Underexpression of SLC5A8 is associated with hepatocellular carcinoma. PMID: 27465549
- Data suggest that SLC5A8, SLC5A5 (sodium-iodide symporter), and SLC26A4 (pendrin), the 3 known iodide transporters, are important in breast tissue metabolism in lactation and in breast neoplasms. [REVIEW] PMID: 26285906
- Gene silencing of SLC5A8 by hypermethylation was associated with poor prognosis in cases of node-negative stage I and II lung adenocarcinoma. PMID: 25827678
- Data indicate oncogenic HRAS (HRAS(G12V)) as a potent mediator of SLC5A8 silencing in human nontransformed normal mammary epithelial cell lines and in mouse mammary tumors through DNMT1. PMID: 23918800
- These results suggest that DNA methylation in the SLC5A8 promoter region may suppress the expression of SLC5A8 in lung tumor. PMID: 23273563
- SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function PMID: 23167260
- SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. PMID: 22450368
- SLC5A8 has a role in prostate cancer risk and aggressiveness PMID: 21802122
- SLC5A8 is highly methylated in African American colon adenomas PMID: 21687703
- Efficacy of LP or their secreted soluble factors to stimulate SMCT1 expression and function and to counteract the inhibitory effects of TNF-alpha on butyrate absorption could have potential therapeutic value. PMID: 20671196
- Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter. PMID: 20211600
- results elucidate the mechanism underlying the regulation of SLC5A8 gene transcription and also define a novel regulatory sequence that may be used to increase expression of the SLC5A8 gene in cancer gene therapy PMID: 20082847
- SMCT1 possesses a anionic leak current that becomes significant whenever external Na(+) concentration is reduced PMID: 19864324
- Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. (hAIT, human apical iodide transporter) PMID: 12107270
- SLC5A8 exon 1 methylation is an early event, detectable in colon adenomas & microscopic aberrant crypt foci. SLC5A8 is a member of the family of sodium solute symporters, now added to the candidate colon cancer suppressor genes. PMID: 12829793
- functional identity of SLC5A8 as a Na(+)-coupled transporter for short-chain fatty acids. PMID: 14966140
- In thyroid carcinomas, the mean and median hAIT mRNA levels were significantly decreased PMID: 15001644
- Data suggest that SLC5A8 functions as a growth suppressor gene in vitro and that it is silenced frequently by epigenetic mechanisms in primary gliomas. PMID: 15867356
- the ability of SLC5A8 to deliver butyrate into colonic epithelial cells most likely underlies the tumor suppressive role of this transporter [review] PMID: 16375929
- Na(+)/monocarboxylate transport expression may be a favorable indicator of colorectal cancer prognosis PMID: 16670197
- Aberrant methylation and hence silencing of TIMP3, SLC5A8, DAPK and RARbeta2, in association with BRAF mutation, may be an important step in PTC tumorigenesis and progression. PMID: 16858683
- SMCT1(SLC5A8) may participate in the intestinal absorption of monocarboxylate drugs. PMID: 17245649
- biophysical analysis of the stoichiometry for the Na+/monocarboxylate cotransporter SMCT1 PMID: 17526579
- DNA methylation in the SLC5A8 promoter region suppressed the expression of SLC5A8 in prostate tumor. PMID: 18037591
- SLC5A8 may function as a tumor suppressor gene whose silencing may contribute to carcinogenesis and progression of pancreatic cancer. PMID: 18437076
- Frequent methylation of SLC5A8 gene is associated with head and neck squamous cell carcinoma PMID: 18559491
- In acute myeloid leukemia with mixed lineage leukemia partial tandem duplication, the SLC5A8 tumor suppressor gene promoter was more frequently hypermethylated. PMID: 18566324
- SLC5A8 mediates the tumor-suppressive effects of the bacterial fermentation product butyrate in the colon PMID: 18661192
顯示更多
收起更多
-
亞細胞定位：Apical cell membrane; Multi-pass membrane protein.
-
蛋白家族：Sodium:solute symporter (SSF) (TC 2.A.21) family
-
組織特異性：Expressed in normal thyroid, localized at the apical pole of thyroid cells facing the colloid lumen, but expression profoundly decreased in thyroid carcinomas. Expressed in normal colon but absent in colon aberrant crypt foci and colon cancers. Present in
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
